"Carbamazepine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An anticonvulsant used to control grand mal and psychomotor or focal seizures. Its mode of action is not fully understood, but some of its actions resemble those of PHENYTOIN; although there is little chemical resemblance between the two compounds, their three-dimensional structure is similar.
| Descriptor ID |
D002220
|
| MeSH Number(s) |
D03.633.300.240.127
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Carbamazepine".
Below are MeSH descriptors whose meaning is more specific than "Carbamazepine".
This graph shows the total number of publications written about "Carbamazepine" by people in this website by year, and whether "Carbamazepine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 1 | 1 |
| 2005 | 1 | 0 | 1 |
| 2010 | 1 | 1 | 2 |
| 2015 | 2 | 0 | 2 |
| 2017 | 1 | 0 | 1 |
| 2019 | 1 | 0 | 1 |
| 2020 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Carbamazepine" by people in Profiles.
-
Material-Sparing and Expedited Development of a Tablet Formulation of Carbamazepine Glutaric Acid Cocrystal- a QbD Approach. Pharm Res. 2020 Jul 23; 37(8):153.
-
Expedited Tablet Formulation Development of a Highly Soluble Carbamazepine Cocrystal Enabled by Precipitation Inhibition in Diffusion Layer. Pharm Res. 2019 Apr 23; 36(6):90.
-
Improving Dissolution Rate of Carbamazepine-Glutaric Acid Cocrystal Through Solubilization by Excess Coformer. Pharm Res. 2017 12 29; 35(1):4.
-
The development of carbamazepine-succinic acid cocrystal tablet formulations with improved in vitro and in vivo performance. Drug Dev Ind Pharm. 2016; 42(6):969-76.
-
Understanding the comparative effectiveness of treatment in pediatric epilepsy: Call to action. Neurology. 2015 Jun 09; 84(23):2298-9.
-
Genome-wide association study identifies HLA-A*3101 allele as a genetic risk factor for carbamazepine-induced cutaneous adverse drug reactions in Japanese population. Hum Mol Genet. 2011 Mar 01; 20(5):1034-41.
-
Comparative effectiveness of 10 antiepileptic drugs in older adults with epilepsy. Arch Neurol. 2010 Apr; 67(4):408-15.
-
Down-regulation of cerebellar 5-HT(2C) receptors in pilocarpine-induced epilepsy in rats: therapeutic role of Bacopa monnieri extract. J Neurol Sci. 2009 Sep 15; 284(1-2):124-8.
-
Blister fluid composition in a pediatric patient with toxic epidermal necrolysis. J Burn Care Res. 2008 Jul-Aug; 29(4):671-5.
-
Oxcarbazepine adjunctive therapy in infants and young children with partial seizures. Neurology. 2005 Nov 08; 65(9):1370-5.